Search results

ANSTO has a full suite of mineralogical, chemical and hydrometallurgical facilities from laboratory through to pilot scale.

Detailed data on ANSTO electricity use and CO2 emissions for FY2024 - FY2025

It is critical across many industries to identify and locate sources of radiation accurately and quickly. By accurately imaging radiation across the full energy range, CORIS360™ improves operational decision making across many industry settings.

Science and medical experts meet in Adelaide to discuss great potential of particle therapy in Australia

The Detection & Imaging group builds on ANSTO’s 70-year history of scientific achievements and contributions in meeting the nuclear needs of industry, globally.

A world-first processing technology developed in collaboration by ANSTO’s Minerals unit.

The High Performance Macromolecular Crystallography beamline will enable the study of very small (sub-5 micrometre) or weakly diffracting crystals, providing a state-of-the-art high-throughput facility for researchers. MX3 will be able to study the structures of large proteins and protein complexes for virology, drug design and industrial applications via goniometer mounted crystals, in-tray screening, or via serial crystallography methods.

The ANSTO Science Series is a live and virtual meet-up that focuses on the key capacities of ANSTO’s people, partners and facilities and how they are meeting global challenges in sustainable industries, medicine, advanced manufacturing and in accelerating small business.

A dedicated team of radiation specialists from the Australian Nuclear Science and Technology Organisation (ANSTO) are behind the successful detection and rapid retrieval of a missing radioactive source in outback Western Australia.

The final report on the safety of Building 23 by the independent expert review team has been completed.

The radiography program focuses on the development of Neutron Capture Enhanced Particle Therapy (NCEPT) from initial preclinical work, to clinical trials and finally commercial translation and licencing.

ANSTO is seeking nominations for the ANSTO Australian Synchrotron Stephen Wilkins Thesis Medal.

Monash University is partnering with the Australian Synchrotron and other key institutions to launch a $2.9 million national project – delivering a robotic laboratory capable of drastically speeding up the invention, trials and commercialisation of medicines by Australian researchers.

ANSTO will make an application to the independent nuclear regulator, ARPANSA, to vary its license for its Interim Waste Store. The original operating license was approved in 2015, enabling the facility to hold what is called a TN-81 cask of intermediate-level radioactive waste that was safely repatriated from France in 2015.

Sample environments, Data analysis, SpICE and SICS

ANSTO welcomes the recent announcement that the inaugural CEO for the Australian Radioactive Waste Agency (ARWA) has been appointed, following a global search. Mr Sam Usher will lead ARWA and comes to the role with almost three decades of experience in the nuclear industry. 

ANSTO is part of a contingent showcasing Australian science at the Australian Pavilion at the World Expo Osaka in October.